Since elevated plasma levels of IGF1 and IGF1R have been observed in early acute respiratory distress syndrome (ARDS)32, it has been suggested that IGF1 may be a potential target in the treatment of COVID-19-related ARDS33. The gene discussed is IGF1; the disease is COVID-19.